CDC NEWS


powered by Surfing Waves


Latest News


Experts Discuss COVID-19—Vaccine Questions, School Openings, and More


17 Mar 2021

JAMA Live Highlights features comments from livestream interviews by JAMA Network Editor in Chief Howard Bauchner, MD. His discussions with experts in clinical care, public health, and health policy focus on critical issues related to the COVID-19 pandemic. Comments have been edited for clarity.


CDC Interim Recommendations for Fully Vaccinated People


10 Mar 2021

On December 11, 2020, the US reached an extraordinary milestone in the efforts to end the COVID-19 pandemic: the Food and Drug Administration authorized emergency use of the first COVID-19 vaccine, manufactured by Pfizer-BioNTech. Since then, 2 additional COVID-19 vaccines, Moderna and Janssen (Johnson & Johnson), have received Emergency Use Authorization in the US and, as of March 8, 2021, more than 31 million people, or 9.4% of the total population, have completed a vaccination series.


Approaches for Optimal Use of Different COVID-19 Vaccines Issues of Viral Variants and Vaccine Efficacy


04 Mar 2021

The efforts of the Biden administration to accelerate rollout of COVID-19 vaccines are enabling more adults in the US to be vaccinated each week. As of February 28, 2021, an estimated more than 48 million people have received at least 1 vaccine dose.


How the Johnson & Johnson Vaccine Works


28 Feb 2021

Johnson & Johnson is testing a coronavirus vaccine known as JNJ-78436735 or Ad26.COV2.S. Clinical trials showed that a single dose of the vaccine had an efficacy rate of up to 72 percent. The vaccine has been authorized for emergency use in the United States and Bahrain.


Janssen COVID-19 Vaccine


27 Feb 2021

On February 27, 2021, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).




Articles


Help Fight Medicare Fraud


30 Dec 2020

Medicare covers the COVID-19 vaccine at no cost to you, so if anyone asks you to share your Medicare Number or pay for access to the vaccine, you can bet it’s a scam.




Both Remote and On-Site Workers are Grappling with Serious Mental Health Consequences of COVID-19


22 Dec 2020

While millions have recently lost their jobs or income and face new stresses, many who have been during the pandemic also face new pressures.




The lightning-fast quest for COVID vaccines — and what it means for other diseases


18 Dec 2020

The speedy approach used to tackle SARS-CoV-2 could change the future of vaccine science.




Trusted Messengers May Help Disenfranchised Communities Overcome Vaccine Hesitancy


17 Dec 2020

MINNEAPOLIS — Gloria Torres-Herbeck gets the flu vaccine every year, but the 53-year-old teacher in Rochester, Minnesota, isn’t yet convinced she wants to be first in line for a potential COVID-19 vaccine.




Enroll for Free